Grenoble, France

Carmen Aguilar

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, Université Grenoble Alpes, Université´ D'aix-Marseille. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carmen Aguilar. Retrieved from https://idiyas.com/inventor/carmen-aguilar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Carmen Aguilar

Introduction

Carmen Aguilar is a distinguished inventor based in Grenoble, France, known for her impactful work in the field of cancer treatment. With a focus on the development of novel compounds, her research aims to tackle significant health challenges, particularly Cushing disease and other cancers. Through her innovative contributions, Aguilar exemplifies the role of inventors in advancing medical science.

Latest Patents

Carmen Aguilar holds one patent titled "Heterocyclic naphthoquinones derivatives for use in the treatment of cancers including Cushing disease." This patent details her invention of heterocyclic naphthoquinone derivatives designed specifically for the treatment of Cushing disease while also targeting other cancers. The mechanism of action involves the inhibition of Ubiquitin Specific Proteases (USP) 8 and/or 2, providing a promising avenue for therapeutic development in oncology.

Career Highlights

Throughout her career, Carmen has made significant strides in the scientific community. She has gained valuable experience while working at notable institutions, including the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and the Université d'Aix-Marseille. Her contributions in these roles have furthered research in cancer therapeutics, showcasing her commitment to enhancing patient outcomes through innovative solutions.

Collaborations

Carmen Aguilar has collaborated with esteemed colleagues in her field, such as Marie-Odile Fauvarque and Magda Mortier. These partnerships have helped foster a collaborative environment, allowing for the exchange of ideas and expertise that enrich her research endeavors. Such collaborations are essential for driving innovation and pushing the boundaries of current medical knowledge.

Conclusion

Carmen Aguilar's dedication to innovation in cancer treatment underscores the importance of inventors in the healthcare landscape. With her pioneering work on heterocyclic naphthoquinones derivatives, she continues to contribute significantly to the scientific community. Her career, marked by collaboration and impactful research, exemplifies the transformative potential of inventive ideas in combating serious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…